Awarded contract

Analysis Credits Waiver for ArcherDX Cancer Service

Awarded
£50k
Published 4 Jun 2026

Waiver authorizing the use of Integrated DNA Technologies ArcherDX Analysis Credits for cancer service genomic testing and clinical reporting.

United Kingdom· EnglandPublished 4 Jun 2026· 2 months agoFind a Tender

Decision brief

4 fields
  • Contract value
    £50,000
    Pounds sterling
  • Closing date
    Rolling
    No closing date published
  • Sector
    Browse related listings
  • Location
    United Kingdom
    England

Suppliers

1 supplier

Lifecycle

Awarded

Contract awarded. Originally published 2 months ago.

4 June 2026
Awarded — no open tender advertised

Brief

This opportunity provides a waiver for Analysis Credits used in cancer service analysis through Integrated DNA Technologies' ArcherDX platform. The service enables genomic analysis and interpretation for cancer diagnostics and treatment planning. Suppliers and healthcare providers can utilize these analysis credits for molecular testing, variant calling, and clinical reporting within the ArcherDX system. This waiver streamlines the procurement process for organizations implementing ArcherDX-based cancer genomics services.

Track record

2 awards · 2 winners
Thin record

Only 2 prior awards here — too little to read.

In this category, Birmingham Women's and Children's NHS Foundation Trust has awarded 2 contracts to 2 suppliers.

Across this category, the most active winners are CARE LINE HOMECARE LIMITED, SPRINGFIELD HOME CARE SERVICES LIMITED, Roche Diagnostics Ltd — the field to beat, or your route in as a partner.

More from Birmingham Women's and Children's NHS Foundation Trust

4 listingsView all →

Open in Healthcare & Medical

4 open listingsView all →